comparemela.com

Latest Breaking News On - Senior pharma analyst - Page 1 : comparemela.com

GlobalData : IGNAZ trial interim results highlight HI-Bio's potential to differentiate in IgAN space, says GlobalData

31 May, 2024 IGNAZ trial interim results highlight HI-Bio s potential to differentiate in IgAN space, says GlobalData Share .

Kajal jaddooEuropean renal associationHuman immunology bioscienceSenior pharma analyst

GlobalData : APPLAUSE-IgAN trial interim analysis highlights Novartis' potential to differentiate in IgAN space, says GlobalData

25 Apr, 2024 APPLAUSE-IgAN trial interim analysis highlights Novartis potential to differentiate in IgAN space, says GlobalData Share .

Kajal jaddooWorld congressSenior pharma analystChinook therapeutics

AstraZeneca's DKD pipeline highlights potential to differentiate in kidney disease space - Pharma News

AstraZeneca's DKD pipeline highlights potential to differentiate in kidney disease space - Pharma News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Kajal jaddooSenior pharma analyst

As Eli Lilly's Q4 results draw near all eyes are on blockbuster weight-loss drug Zepbound

Demand has far outstripped the pharma major's own projections, sparking concerns about the drug's availability

Anoop misraEli lillyNovo nordisk wegovyNovo nordiskNational diabetesLilly answers centerObesity cholesterol foundationSara reciSenior pharma analystLilly answersWeight loss drug

GlobalData : Positive post hoc analysis of SCORED trial to bolster Inpefa use for heart failure, says GlobalData -November 22, 2023 at 01:46 am EST

22 Nov, 2023 Positive post hoc analysis of SCORED trial to bolster Inpefa use for heart failure, says GlobalData Share .

United statesKajal jaddooAmerican heart association scientific sessionLexicon pharmaceuticalSenior pharma analyst

vimarsana © 2020. All Rights Reserved.